Predictors of Long-Term Survival in Patients with Lung Cancer Included in the Randomized Spanish Lung Cancer Group 0008 Phase II Trial Using Concomitant Chemoradiation with Docetaxel and Carboplatin plus Induction or Consolidation Chemotherapy

Pilar Garrido; Rafael Rosell; Bartomeu Massutí; Felipe Cardenal; Vicente Alberola; Manuel Dómine; Inmaculada Maeztu; Alfredo Ramos; Antonio Arellano

doi:10.3816/clc.2009.n.025

Predictors of Long-Term Survival in Patients with Lung Cancer Included in the Randomized Spanish Lung Cancer Group 0008 Phase II Trial Using Concomitant Chemoradiation with Docetaxel and Carboplatin plus Induction or Consolidation Chemotherapy

Clinical Lung Cancer ◽

10.3816/clc.2009.n.025 ◽

2009 ◽

Vol 10 (3) ◽

pp. 180-186 ◽

Cited By ~ 14

Author(s):

Pilar Garrido ◽

Rafael Rosell ◽

Bartomeu Massutí ◽

Felipe Cardenal ◽

Vicente Alberola ◽

...

Keyword(s):

Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Consolidation Chemotherapy ◽

Term Survival ◽

Long Term Survival ◽

Cancer Group ◽

Concomitant Chemoradiation

Download Full-text

Predictors of long-term survival in lung cancer patients (p) included in the randomized Spanish Lung Cancer Group 0008 phase II trial using concomitant chemoradiation with docetaxel (D) and carboplatin (Cb) plus induction (I) or consolidation (C) chemotherapy (CT) with docetaxel and gemcitabine (G)

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.7574 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 7574-7574

Author(s):

P. Garrido Lopez ◽

R. Rosell ◽

B. Massutí ◽

F. Cardenal ◽

V. Alberola Candel ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

Term Survival ◽

Long Term Survival ◽

Lung Cancer Patients ◽

Cancer Group ◽

Concomitant Chemoradiation

Download Full-text

Phase II trial of 21-day regimen of irinotecan and carboplatin for chemonaive or relapsed small-cell lung cancer: Long-term survival

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.19009 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 19009-19009

Author(s):

G. Q. Chen ◽

M. Huynh ◽

L. Fehrenbacher ◽

A. M. Davies ◽

H. West ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Term Survival ◽

Long Term Survival

Download Full-text

Randomized phase II trial of non-platinum induction or consolidation chemotherapy plus concomitant chemoradiation in stage III NSCLC patients: Mature results of the Spanish Lung Cancer Group 0008 study

Lung Cancer ◽

10.1016/j.lungcan.2013.03.009 ◽

2013 ◽

Vol 81 (1) ◽

pp. 84-90 ◽

Cited By ~ 18

Author(s):

Pilar Garrido ◽

Rafael Rosell ◽

Antonio Arellano ◽

Francisco Andreu ◽

Manuel Dómine ◽

...

Keyword(s):

Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Stage Iii ◽

Consolidation Chemotherapy ◽

Cancer Group ◽

Randomized Phase Ii ◽

Concomitant Chemoradiation ◽

Stage Iii Nsclc ◽

Nsclc Patients

Download Full-text

Addition of amifostine to the CHOP regimen in elderly patients with aggressive non-Hodgkin lymphoma: a phase II trial showing reduction in toxicity without altering long-term survival

Hematology/Oncology and Stem Cell Therapy ◽

10.5144/1658-3876.2012.152 ◽

2012 ◽

Vol 5 (3) ◽

pp. 152-157 ◽

Cited By ~ 1

Author(s):

Henry L. Gómez ◽

César Samanéz ◽

Frank Campana ◽

Silvia P. Neciosup ◽

Luis Vera ◽

...

Keyword(s):

Elderly Patients ◽

Hodgkin Lymphoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Chop Regimen ◽

Term Survival ◽

Long Term Survival ◽

Non Hodgkin Lymphoma

Download Full-text

WITHDRAWN: Addition of amifostine to CHOP regimen significantly reduced toxicity in patients with aggressive non-Hodgkin’s lymphoma without affecting the long term survival: Results of a phase II trial

Hematology/Oncology and Stem Cell Therapy ◽

10.1016/j.hemonc.2012.10.001 ◽

2013 ◽

Author(s):

Henry L. Gómez

Keyword(s):

Phase Ii ◽

Hodgkin’S Lymphoma ◽

Phase Ii Trial ◽

Hodgkin's Lymphoma ◽

Chop Regimen ◽

Term Survival ◽

Long Term Survival ◽

Non Hodgkin's Lymphoma ◽

Reduced Toxicity

Download Full-text

Long term survival in IMAGE 1 (Immune Modulation And Gemcitabine Evaluation 1), a randomized, open-label phase II trial comparing gemcitabine with and without IMM-101 in advanced pancreatic cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.3051 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 3051-3051

Author(s):

Angus George Dalgleish ◽

Keyword(s):

Pancreatic Cancer ◽

Phase Ii ◽

Immune Modulation ◽

Phase Ii Trial ◽

Advanced Pancreatic Cancer ◽

Open Label ◽

Term Survival ◽

Long Term Survival ◽

Open Label Phase

Download Full-text

Randomized phase II trial of CODE or AP after chemoradiotherapy for LD-SCLC: Long-term survival and toxicity analysis

Annals of Oncology ◽

10.1093/annonc/mdz264.005 ◽

2019 ◽

Vol 30 ◽

pp. v712

Author(s):

Sekine ◽

H. Harada ◽

N. Yamamoto ◽

M. Wakabayashi ◽

H. Murakami ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Term Survival ◽

Long Term Survival ◽

Randomized Phase Ii ◽

Toxicity Analysis

Download Full-text

Long-term survival of a patient with small cell lung cancer after eight lines of chemotherapy and radiation

Pneumologie ◽

10.1055/s-2007-973149 ◽

2007 ◽

Vol 61 (S 1) ◽

Author(s):

O Gressner ◽

U Mey ◽

T Sauerbruch ◽

M Gorschlüter

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Term Survival ◽

Long Term Survival

Download Full-text

Resection of a solitary brain metastasis in a patient with small cell lung cancer—Long-term survival

European Journal of Cancer ◽

10.1016/0959-8049(94)00491-m ◽

1995 ◽

Vol 31 (3) ◽

pp. 419 ◽

Cited By ~ 9

Author(s):

R.P. Abratt ◽

M. de Groot ◽

P.A. Willcox

Keyword(s):

Lung Cancer ◽

Brain Metastasis ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Term Survival ◽

Solitary Brain Metastasis ◽

Long Term Survival

Download Full-text

10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45Gy (1.5Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)—A multicenter phase-II trial (CISTAXOL)

Lung Cancer ◽

10.1016/j.lungcan.2013.06.007 ◽

2013 ◽

Vol 82 (1) ◽

pp. 83-89 ◽

Cited By ~ 13

Author(s):

Wilfried Ernst Erich Eberhardt ◽

Thomas Christoph Gauler ◽

Cecile LePechoux ◽

Georgios Stamatis ◽

Stephan Bildat ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii Trial ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Term Survival ◽

Multicenter Phase

Download Full-text